As of the beginning of 2022, the new coronavirus that has ravaged the world for nearly two years has infected nearly 280 million people and taken more than 10 million lives, and these two figures have not yet stopped.

　　The new crown epidemic is like a heavy stone, pressing on the hearts of people all over the world.

　　However, there is finally good news of a major breakthrough recently: Robot 365 scientific research team has successfully developed the world's first artificial intelligence stem cell cultivation equipment, which can effectively help biomedical research and development, serve human health, and strongly support the development of the global smart medical industry!

　　Liu Zhaoqiang, founder of Robot 365, was interviewed by government media

　　Adhering to the corporate vision and mission of "let artificial intelligence technology create medical value", the Robot 365 team has always been committed to developing easy-to-operate, flexible, safe and efficient intelligent medical robots for the medical industry.

　　Liu Zhaoqiang, the head of the company, told reporters that its Robot 365 R&D Center in Songshan Lake National High-Tech Demonstration Zone has been officially opened, and will continue to develop more high-quality medical robot products in the future.

　　"Scientific and technological innovation, breakthrough development", making China the forefront of the global R&D and application of smart medical robot products, benefiting global human health, this is an important direction for the development of the Robot 365 R&D team.

　　The ability to do this is due not only to the breakthroughs in China's innovative development strategy and technological innovation policy, but also to the ten-year layout and hard work of the Robot 365 team.

　　01 After ten years of hard work, the fragrance of plum blossoms comes from the bitter cold

　　Robot 365 Artificial Intelligence Knowledge Graph

　　As early as 2010, the core members of the Robot 365 R&D team were the first domestic teams engaged in the R&D and market application of intelligent robot products, with solid technical foundation and experience.

　　The Robot 365 R&D Center has grown from scratch, one step at a time, taking every step steadfastly. For a long time, the Robot 365 team has always adhered to the innovative business philosophy of "achieving customers and working hard", and has continued to invest for many years. Finally, with the blessing of policy dividends, it has achieved fruitful results, and has repeatedly created medical robot products. The speed of listing and sales records. .

　　Robot 365 Core Products

　　In recent years, Robot 365 has won nearly 50 national patents and a number of trademark soft copyright intellectual property rights. There are more than 150 patents in the application, and many of the authorized invention patents have industry-leading value and high gold content.

　　Looking at the world, smart medical care has always been optimistic about domestic and foreign industry capital and enterprises, with unlimited prospects. However, the reality is not as good as the consulting report predicted. It is not easy to achieve high-speed growth. Expensive time and capital are invested in it, and the ideal return has not been seen for a long time. Some companies have to withdraw.

　　Why is Robot 365 unique? Why does Robot 365 accurately capture policy dividends and grow steadily? Through the reporter's in-depth interview with the founder of Robot 365, Liu Zhaoqiang, we finally found the answer to this question.

　　02 "R&D" is the strategy of Robot 365

　　Since its establishment, Liu Zhaoqiang has led Robot 365 all the way forward. He believes that Robot 365 can reach today thanks to its long-term vision, clear strategy and firm confidence.

　　Liu Zhaoqiang recalled that at the beginning of the establishment of Robot 365, there were less than 20 people in total, and the talent structure of the team was incomplete. There were very few people who really had experience in technical research. On the other hand, the development of innovative products could not be carried out.

　　Robot 365 firmly invests in research and development for two reasons: "First, China's intelligent manufacturing has reached the international synchronization or even leading level after several years of rapid development. Changes in the intelligent medical industry will soon come, and the market potential is huge. Second, the R&D team of Robot 365 has a clear layout. Although the team is young, it is enthusiastic and motivated." Liu Zhaoqiang concluded.

　　Robot 365 R&D Center

　　Returning to the original intention of Robot 365, an artificial intelligence company, profit has never been their first consideration in technology research and development.

　　"We should always remember that artificial intelligence is produced for human beings, not for the pursuit of profit. As long as we stick to this belief, profits will follow." The words of Liu Zhaoqiang, founder of Robot 365, are firm and calm, Full of confidence, chances must favor those who are well prepared.

　　On December 7, 2021, the Ministry of Industry and Information Technology of the People's Republic of China and the National Health and Health Commission jointly issued a letter to collect a batch of typical robot scenarios with high technical level, mature application mode and significant application effect in the medical field, and guide robot companies to strengthen cooperation with medical institutions , to develop more advanced and applicable medical robots that are more suitable for application scenarios. This landmark document is bound to promote the rapid development of China's artificial intelligence medical industry.

　　03 Robot 365 Speed: Strategy and Talent

　　Robot 365 Engineer

　　"The successful research and development of the stem cell cultivation robot has been highly recognized by customers, and the completion of angel investment are the two things we are most proud of in the past decade." Liu Zhaoqiang said, because this is a successful work that truly meets the needs of China's medical research scene.

　　In 2020, Zhongxu Biological Group, the first customer of Robot 365, had signed a purchase order for foreign robotic equipment. Due to the impact of the epidemic, foreign equipment researchers could not go to China for installation and debugging, so they had to cancel the foreign order and instead Find replacement equipment domestically.

　　The R&D team of Robot 365 rose to the challenge and not only completed the equipment installation and delivery as scheduled, but also received high recognition from customers. This is a full affirmation of the team's technical talent capabilities, and it also strengthens the team's strategic goal of deep cultivation in artificial intelligence medical scenarios.

　　Robot 365 intelligent medical laboratory scene

　　"From a business perspective alone, large-scale investment in some fields may not necessarily yield high returns, but as long as innovation is to meet the high-quality development of the country and the needs of social and public health, artificial intelligence technology can create medical value and give Providing hope in the future is a meaningful job in life. No difficulties can stop our progress." Liu Zhaoqiang said.

　　In terms of scheme design, Robot 365 is also a unique way. Artificial intelligence and biomedicine are two completely different fields. The technical standards used in the development and production of robots have to be adjusted a lot in the field of stem cells. This is an obvious crossover.

　　Innovation is not a shortcut, it is openness and inclusiveness under the condition of fully mastering basic theoretical knowledge, daring to break through challenges, and find an effective path to finally solve the problem. This is what the R&D team of Robot 365 has achieved. Every design drawing and every program code carefully listens to the suggestions of customers, and uses professionalism to create quality, which reflects the ingenuity of Chinese robot engineers.

　　04 Rich product development pipeline

　　It is well known to the outside world that Robot 365 has a large investment and a large output in the field of stem cell cultivation equipment. But in fact, the R&D pipeline of Robot 365 itself has been deployed in many intelligent medical fields, and it has become the cradle of the output of various artificial intelligence medical equipment.

　　Now the Robot 365 R&D Center is not only to create innovative products, but also to ensure that innovation does not lag behind other countries, and to provide artificial intelligence medical equipment that is synchronized or even leading the international level to global users. This is the core strategy of the Robot 365 R&D Center in the future. , that is, we hope to achieve "diversified development and simultaneous innovation".

　　05 New goals for the future: more, faster, updated

　　Looking back on the past, it was fruitful. Today's Robot 365 has planned a new development goal - "more, faster, and newer".

　　"More" means having more choices and a greater right to speak.

　　"Faster" means "high-speed innovation", creating the world's leading research and development highland for artificial intelligence medical equipment.

　　"Update" refers to building new R&D capabilities while meeting existing R&D capabilities.

　　Everything in the past is a prologue.

　　Robot 365 has set sail. "We hope to join hands with the government, other multinational enterprises, and local enterprises to enhance our overall R&D strength and enhance the innovation capability of China's artificial intelligence medical care." Liu Zhaoqiang is full of confidence, "Together for the grand goal of Healthy China 2030 Make our contribution!